Lazard Asset Management LLC Taro Pharmaceutical Industries LTD Transaction History

Lazard Asset Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 13, 2020	SELL	$54.41 - $68.2 $3,427 - $4,296	-63 Closed	0 $0
Q2 2020 Aug 13, 2020	SELL	$61.66 - $70.16 $9,680 - $11,015	-157 Reduced 71.36%	63 $4,000
Q1 2020 May 14, 2020	BUY	$59.35 - $88.73 $13,057 - $19,520	220 New	220 $13,000
Q4 2019 Feb 13, 2020	SELL	$74.18 - $97.92 $12,684 - $16,744	-171 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$75.36 - $86.57 $12,886 - $14,803	171 New	171 $12,000

14.8K

Ticker TARO
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 37,584,600
Description
Taro Pharmaceutical Industries Ltd., a science-based pharmaceutical company, develops, manufactures, and markets prescription and over-the-counter pharmaceutical products in the United States, Canada, Israel, and internationally. The company also develops and manufactures active pharmaceutical ingredients primarily for use in its finished dosage...

Get notified when there are updates to the investment portfolio of Lazard Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Lazard Asset Management LLC with notifications on news.